PBLS — Parabilis Medicines, Inc.
Price · 2026-06-10 → 2026-08-21
51 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2026-06-10.
Performance
Technicals
Measured signals that fired on PBLS
| date | signal | measured base rate |
|---|---|---|
| 2026-06-15 | Cluster buy: three or more insiders insider | +0.63% over 21 days · t = 1.84 · n = 3,050 not distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-22 | Kolchinsky Peter Director | Open-market purchase | 47.2K | 29.77 | 1.4M |
| 2026-07-22 | Shah Rajeev M. Director | Open-market purchase | 47.2K | 29.77 | 1.4M |
| 2026-07-22 | RA Capital Nexus Fund III, L.P. Director | Open-market purchase | 47.2K | 29.77 | 1.4M |
| 2026-07-22 | RA CAPITAL MANAGEMENT, L.P. Director | Open-market purchase | 47.2K | 29.77 | 1.4M |
| 2026-07-22 | RA Capital Healthcare Fund LP Director | Open-market purchase | 47.2K | 29.77 | 1.4M |
| 2026-07-21 | RA Capital Nexus Fund III, L.P. Director | Open-market purchase | 37.7K | 30.00 | 1.1M |
| 2026-07-21 | Kolchinsky Peter Director | Open-market purchase | 37.7K | 30.00 | 1.1M |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. Director | Open-market purchase | 37.7K | 30.00 | 1.1M |
| 2026-07-21 | RA Capital Healthcare Fund LP Director | Open-market purchase | 37.7K | 30.00 | 1.1M |
| 2026-07-21 | Shah Rajeev M. Director | Open-market purchase | 37.7K | 30.00 | 1.1M |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Parabilis Medicines, Inc. (PBLS) filed form 8-K · 2026-08-13 · SEC EDGAR
Ask the AI about PBLS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →